Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Diseases

Hematopoietic stem cell transplantation for severe Crohn's disease

Bone Marrow Transplantation volume 32, pages S57–S59 (2003)Cite this article

Summary:

It is clear that some patients with severe Crohn's disease (CD) fail to respond favorably to the standard treatment, including antibody to Tumor Necrosis Factor alpha (TNFα), We have embarked on a unique therapy for this group of patients, intense immune suppression followed by autologous hematopoietic stem cell transplantation (HSCT). The response to this approach in our first four patients has been excellent, with there being no significant untoward event from the transplantation and with each patient entering clinical remission in terms of the Crohn's Disease Activity Index off all therapy for CD and no diarrhea or abdominal pain. However, some evidence of minor laboratory abnormalities and slight inflammation of the colon on colonoscopic evaluation persist up to 1 year post-transplant. It is suggested that HSCT should be considered a reasonable option for patients who have failed standard CD therapy, although long-term follow-up will be necessary to confirm the duration of the induced clinical remission.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Rao SS, Cann PA, Holdsworth CD . Clinical experience of the tolerance of mesalazine and olsalazine in patients intolerant of sulfasalazine. Scand J Gastroenterol 1987; 22: 332–336.

    Article  CAS  Google Scholar 

  2. Summers RW, Switz DM, Sessions Jr JT et al. National Cooperative Crohn's Disease Study: Results of drug treatment. Gastroenterology 1979; 77: 847–869.

    CAS  PubMed  Google Scholar 

  3. Bar-Meir S, Chowers Y, Lavy A et al. Budesonide versus prednisone in the treatment of active Crohn's disease. Gastroenterology 1998; 115: 835–840.

    Article  CAS  Google Scholar 

  4. Willoughby JM, Becket J, Kumar PJ, Dawson JM . Controlled trial of azathioprine in Crohn's disease. Lancet 1971; 2: 944–947.

    Article  CAS  Google Scholar 

  5. Present DH, Korelitz BI, Wisch N et al. Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study. N Engl J Med 1980; 302: 981–987.

    Article  CAS  Google Scholar 

  6. Markowitz J, Grancher K, Kohn N et al. A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease. Gastroenterology 2000; 119: 895–902.

    Article  CAS  Google Scholar 

  7. Brynshov J, Freund L, Rasmussen SN et al. A place-bo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease. N Engl J Med 1989; 321: 845–850.

    Article  Google Scholar 

  8. Kozarek RA, Patterson DJ, Gelfand MD et al. Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease. Ann Intern Med 1989; 110: 353–356.

    Article  CAS  Google Scholar 

  9. Neurath MF, Wanitschke R, Peters M et al. Randomized trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn's disease. Gut 1999; 44: 625–628.

    Article  CAS  Google Scholar 

  10. Targan S, Hanauer SB, van Deventer SJH et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor a for Crohn's disease. N Engl J Med 1997; 337: 1029–1035.

    Article  CAS  Google Scholar 

  11. Present DP, Rutgeerts P, Targan S et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med 1999; 340: 1398–1405.

    Article  CAS  Google Scholar 

  12. Fedorak RN, Gangl A, Elson CO et al. Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. Gastroenterology 2000; 119: 1473–1482.

    Article  CAS  Google Scholar 

  13. Bernstein LH, Frank MS, Brant LJ, Boley SJ . Healing of perineal Crohn's disease with metronidazole. Gastroenterology 1980; 79: 357–365.

    CAS  PubMed  Google Scholar 

  14. Farmer RG, Hawk WA, Turnbull RB . Clinical patterns in Crohn's disease: a statistical study of 615 cases. Gastroenterology 1975; 68: 627–639.

    CAS  PubMed  Google Scholar 

  15. Farmer RG, Whelan G, Fazio VW . Long-term follow-up of patients with Crohn's disease. Relationship of the clinical pattern and prognosis. Gastroenterology 1985; 88: 1818–1827.

    Article  CAS  Google Scholar 

  16. Lapidus A, Bernell O, Hellers G, Lofberg R . Clinical course of colorectal Crohn's disease: a 35 -year follow-up study of 507 patients. Gastroenterology 1998; 114: 1151–1160.

    Article  CAS  Google Scholar 

  17. Loftus EV, Silverstein MD, Sandborn WJ et al. Crohn's disease in Olmsted county, Minnesota, 1940–1993: incidence, prevalence, and survival. Gastroenterology 1998; 114: 1161–1168.

    Article  Google Scholar 

  18. Lopez-Cubera SO, Sullivan KM, McDonald GB . Course of Crohn's disease after allogeneic bone marrow transplantation. Gastroenterology 1998; 114: 433–440.

    Article  Google Scholar 

  19. Drakos PE, Nagler A, Or R . Case of Crohn's disease in bone marrow transplantation. Am J Hematol 1993; 43: 157–158.

    Article  CAS  Google Scholar 

  20. Kashyap A, Foreman SJ . Autologous bone marrow transplantation for non-Hodgkin's lymphoma resulting in long term remission of coincidental Crohn's disease. Br J Haematol 1998; 103: 651–652.

    Article  CAS  Google Scholar 

  21. Castro J, Benich HI, Smith HL . Prolonged clinical remission in patients with inflammatory bowel disease after high dose chemotherapy and autologous bone marrow stem cell transplantation. Blood 1996; 88: 133A.

    Google Scholar 

  22. Best WR, Becktel JM, Singleton JW, Kern F . Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976; 70: 843–850.

    Google Scholar 

  23. Burt RK, Traynor AE, Oyama Y, Craig R . High-dose immune suppression and autologous hematopoietic stem cell transplantation in refractory Crohn's Disease. Blood 2003; 101: 2064–2066.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Immunotherapy, Northwestern University Medical Center, Chicago, IL, USA

    R M Craig, A Traynor, Y Oyama & R K Burt

Authors
  1. R M Craig
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A Traynor
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Y Oyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R K Burt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R K Burt.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Craig, R., Traynor, A., Oyama, Y. et al. Hematopoietic stem cell transplantation for severe Crohn's disease. Bone Marrow Transplant 32 (Suppl 1), S57–S59 (2003). https://doi.org/10.1038/sj.bmt.1703945

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1703945

Keywords

This article is cited by

Search

Advanced search

Quick links